small molecule therapeutics (Nanyang Normal University)

N/A

Report date: 2025/01/26 17:05:31
NME

Base Information

Drug Namesmall molecule therapeutics (Nanyang Normal University)
Drug Alias NameTM-2 (Nanyang Normal University)TM-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase B inhibitorsAcetylcholinesterase inhibitors
TargetsAcetylcholinesteraseMonoamine oxidase B
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanyang Normal University
China Registration ClassN/A

Develop Information

Active CompaniesNanyang Normal UniversityGuizhou Medical UniversityHenan University
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A